Stay updated on MOST: Stroke Thrombolysis Clinical Trial
Sign up to get notified when there's something new on the MOST: Stroke Thrombolysis Clinical Trial page.
Latest updates to the MOST: Stroke Thrombolysis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter now shows Revision: v3.3.2, replacing Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check21 days agoChange DetectedEditorial wording now indicates that publications are automatically filled in from PubMed and the revision tag changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check29 days agoChange DetectedRemoved the site-wide funding-status notice. The MOST study details, eligibility criteria, and outcomes information remain unchanged.SummaryDifference0.2%
- Check43 days agoChange DetectedResults have been posted for the MOST trial, and the study status/dates have been updated (including the last update and completion dates).SummaryDifference0.3%
- Check57 days agoChange DetectedAdded a new prespecified subgroup analysis publication from the MOST Trial (thrombolysis alone vs with Argatroban/Eptifibatide) with full citation and author list. No deletions detected.SummaryDifference2%
- Check71 days agoChange DetectedRelease v3.2.0 includes a critical government-funding status notice and links for operating status, replacing the previous v3.1.0.SummaryDifference3%
Stay in the know with updates to MOST: Stroke Thrombolysis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MOST: Stroke Thrombolysis Clinical Trial page.